Board table

Western Sydney Local Health District

Our Committees

WSLHD Board Committees

Health Care Quality Committee

Purpose: To ensure the Western Sydney Local Health District has appropriate patient safety and clinical quality systems to monitor performance and to continuously improve patient care. The HCQC will fulfill this by following these objectives:

  • provide leadership for improving the quality and models of health care in the Local Health District
  • review the Local Health District’s implementation of the NSW Ministry of Health’s Patient Safety Clinical Quality program
  • monitor the performance against the Safety and Quality indicators within the Service Agreement and determine strategies to address any areas of concern
  • review and monitor clinical quality indicators
  • to escalate high risks issues or concerns in relation to patient safety and clinical quality to the Board
  • to support WSLHD in building the necessary capability and capacity for quality improvement

Chair: Professor Michael Hollands
Executive Sponsor: Joanne Edwards, Executive Director Nursing & Midwifery and Clinical Governance
Secretariat: Sandra Jones, Executive Assistant to Director Clinical Governance 

Medical Staff Executive Council

Purpose: The Local Health District is required by the 2011 Model By-Law under the Health Services Act to establish Medical Staff Councils and a Medical Staff Executive Council.

  1. The objectives of the Medical Staff Council (and Clinical Council) structures are to:
    • facilitate effective patient care and services through a co-operative approach to the management and efficient operation of public hospitals between hospital executive management, clinical staff and clinical support staff
    • provide a forum for information sharing and to support feedback to staff on issues affecting the administration of the hospitals through the members of the councils
  2. The Medical Staff Executive Council is composed of representatives of the Medical Staff Councils for the hospitals under the control of then local health district
  3. The functions of the Medical Staff Executive Council are to:
    • provide advice to the Chief Executive and Board on medical matters
    • nominate, every 3 years from the date of issuing of the above By-Law, a short list of up to 5 medical practitioners to be available to the Minister for Health when considering the appointment of a member or members of the Board

Sponsor: Professor Chris Liddle

Medical and Dental Appointments Advisory Committee

Purpose: The purpose of the Medical and Dental Appointments Advisory Committee (the committee) is to:

  1. provide advice, and where appropriate make recommendations with reasons, to the Chief Executive concerning matters relating to the appointment or proposed appointment of visiting practitioners, staff specialists or dentists
  2. consider any application that has been referred to the committee by the Chief Executive for:
    • appointment of a visiting practitioner, staff specialist or dentist; or
    • a proposal to appoint a person as a visiting practitioner, staff specialist or dentist
  3. provide advice and, where appropriate, make recommendations with reasons to the Chief Executive concerning the clinical privileges, which should be allowed to visiting practitioners, staff specialists and dentists

The committee may form subcommittees, whether at a hospital or otherwise, to provide advice or other assistance to enable it to perform duties referred to above.

Chair: Mr Andrew Bernard
Executive Sponsor: Doug Catchpole, Director Corporate Governance
Secretariat: Alison King, Specialist Medical and Dental Recruitment Unit
Contact Unit: Specialist Medical and Dental Recruitment Unit

Finance, Performance and Assets Management Committee

Purpose:  The functions of the Finance, Performance and Assets Management Committee of the Board are to oversee Western Sydney LHD’s strategic approach to finance, operational performance and capital works/assets and monitor, review and recommend actions to the Board on:

  • the financial strategies and policies underpinning financial performance, operational performance and capital assets
  • endorse, review and monitor compliance with the annual service agreement
    WSLHD Strategic Plan and operational plans
  • strategic issues concerning financial sustainability of the WSLHD
  • WSLHD's cash position and capacity to pay its bills on time
  • strategic and other issues arising from the WSLHD's management of investments
  • statutory requirements including approval and endorsement of cash payments reporting status of investments and other approvals and endorsements as may be required 
  • operational performance, and report to the Board progress and issues arising in the operational performance, with regard to the Service Agreement, KPIs set by the Ministry of Health, and other considerations
  • strategies for WSLHD's current and future capita l assets to ensure that the WSLHD has available to it appropriate and functional facilities, and engineering and other services to deliver effective, patient-centred health care in the right place, at the right time, and consistent with the costs set by the MOH's Activity-based Funding prices

Chair: Andrew Bernard, WSLHD Board member
Executive sponsor: Barry Mitrevski, A/Chief Financial Officer
Secretariat: Christian Jansen
Committee members: Danny O'Connor, Chief Executive
Jeremy Chapman, WSLHD Board member
Brett Thompson, General Manager Westmead & Auburn Hospital
Sue-Anne Redmond, General Manager Blacktown Mount Druitt hospitals
Robynne Cooke, Executive Director Operations
Elizabeth Andersen, Deputy Director Finance
David Rogers, Independent Member

Research Development Committee

Purpose: The WSLHD Research Development Committee has been established to provide leadership for the development of research and to ensure high quality research is translated into improved clinical care in WSLHD. As a Committee of the Board, the Committee is responsible for the governance of research within the LHD and provides assurance to the Board on research activities.

Following are the responsibilities of the Research Development Committee:

  • To provide strategic leadership for fostering research within the WSLHD
  • To provide strategic leadership for WSLHD as a partner in the Westmead Research Hub, the Sydney Health Partners (AHRTC) and other research activities as determined by the WSLHD Governing Board
  • To seek assurance on the Local Health District’s implementation of its research strategies
  • To monitor performance against research related key performance indicators within the Service Agreement
  • To review and monitor research key performance indicators and work plan aligned to the strategic priorities.
  • To act as an escalation point from the Executive to assess high risk issues or concerns in relation to patient safety as a result of research
  • To report to the Board on matters of strategic importance in alignment with the WSLHD Governing Board work plan.

Chair: Professor Jeremy Chapman AC
Executive Sponsor: Joanne Edwards, Executive Director Nursing & Midwifery and Clinical Governance
Secretariat: Mark T Smith, Research and Education Network
Contact Unit: Research and Education Network wslhd-ren@health.nsw.gov.au

Audit and Risk Committee

Purpose: The purpose of the Audit and Risk Committee (ARC) is to provide independent assistance to the Board and Chief Executive by monitoring, reviewing and providing advice about the organisation’s governance processes, risk management and control frameworks, and its external accountability obligations.

The Board has established an Audit and Risk Committee, with the following core responsibilities:

  • to assess and enhance the organisation’s corporate governance, including its systems of internal control, ethical conduct and probity, risk management, management information and internal audit
  • to ensure that appropriate procedures and controls are in place to provide reliability in the Organisation’s financial reporting, safeguarding of assets, and compliance with the Organisation’s responsibilities, regulatory requirements, policies and procedures
  • to oversee and enhance the quality and effectiveness of the Organisation’s internal audit function, providing a structured reporting line for the Internal Auditor and facilitating the maintenance of their independence
  • through the internal audit function, to assist the Board to deliver the Organisation’s outputs efficiently, effectively and economically, so as to obtain best value for money and to optimise organizational performance in terms of quality, quantity and timeliness
  • to maintain a strong and candid relationship with external auditors, facilitating to the extent practicable, an integrated internal/external audit process that optimises benefits to the organisation

Chair: Mr Barry Shepherd, Independent member
Executive Sponsor: Mohan Hariharan, Acting Director Internal Audit
Secretariat: Margaret Taofi, Assistant Auditor & Executive Assistant
Committee members: Ms Carolyn Walsh, Independent member and Mr Arthur Butler, Independent Member

Aboriginal Health Collaborative

The Western Sydney Aboriginal Health Collaborative has been established with representatives from Western Sydney Local Health District (WSLHD), Western Sydney PHN (WentWest), Sydney Children’s Hospital Network (SCHN) and the new Aboriginal Medical Service (AMS).

Purpose: The Collaborative is guided by the principles of the WSLHD/WentWest/SCHN Partnership Memorandum. Its purpose is to develop and drive implementation of joint priorities with the aim of improving Aboriginal health and wellbeing in western Sydney and identifying and appropriately responding to the health needs of the Aboriginal community in western Sydney.

The Western Sydney Aboriginal Health Collaborative will act as a Sub-Committee to the WSLHD Board.

The first meeting of the Western Sydney Aboriginal Health Collaborative took place on 5 December 2016. The Chair and secretariat will be rotated on an annual basis and it was agreed that the Western Sydney PHN (WentWest) will provide secretariat and Chair the meeting during 2017.

The Collaboration agreed as first priority to review Aboriginal health plans from each of the organisations towards alignment of a single health plan which incorporates which outlines a shared vision, common goals, priorities and KPIs and measures of success. This joint plan will also have costed deliverables and will form the basis for future co-commissioning around Aboriginal health.

Chair: Walter Kmet, CEO WentWest
Executive Sponsor: Victoria Nesire, Executive Director Integrated and Community Health, WSLHD
Secretariat: Melissa Gibson, Director Partnership Development and Community Engagement, WentWest
Membership: The group consists of 12 members



Section Menu